Patient advocacy and access to innovative clinical trials in a changed environment (COVID 19)
1:29:30
Clinical Research Services Webinars
-
Webinar: A Guide to Conducting Clinical Trials in China, Regulatory and SSU factors
57:27
-
ICON’s World Children’s Day: Special Panel Discussion
1:56:22
-
What is the link between pharmacovigilance and building confidence around COVID-19 vaccines
59:22
-
Decentralised and hybrid trials - engaging important stakeholders: Patients and investigators
59:47
-
Webinar: Building resilience in pharma R&D by decentralising and digitising
1:00:54
-
Engaging physicians in a healthcare setting to increase research activity
54:46
-
Managing safety reporting in the evolving regulatory environment of the Asia-Pacific region
51:38
-
Imaging AI and machine learning: Beyond the hype
1:02:26
-
Reducing site burden and increasing trial efficiency
55:49
-
Pharmacovigilance compliance and robust oversight at the affiliate level webinar
59:10
-
ICH E9 (R1) Estimands and Sensitivity Analyses in clinical trials
1:05:59
-
Preparing for the new world of drug safety: Embracing cloud and AI
1:01:31
Commercialisation & Outcomes Webinars
-
Qualitative longitudinal research in patient-centred research
57:53
-
A guide to conducting clinical trials in China
59:44
-
Webinar: How to increase engagement with medical and scientific posters using enhanced digital content and design
1:00:25
-
Webinar: Using external control arm studies in HTA submissions
1:01:43
-
Webinar: Using wearables data to support drug reimbursement
1:02:43
-
The value of early-phase medical communication planning
56:53
-
HTA and market access implications for gene therapies learnings for future products
1:03:10
-
Using R Shiny to create interactive and web-based health economic models - challenges and opportunities
1:02:15
-
Health economic assessments in France (CEESP-HAS)
59:03
-
Real world data mapping
59:12
-
Using early scientific advice in drug development: Opportunities and challenges
1:00:28
-
Integrating qualitative patient interviews into a clinical trial protocol
56:34
